Cycleron Ther Rg
Cycleron Therapeutics, Inc. is a clinical‑stage biopharma developing phase‑II soluble guanylate cyclase (sGC) stimulators—Olinciguat for cardiovascular disease and Praliciguat for rare kidney disease—backed by a strategic license with Akebia and headquartered in Cambridge, MA.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 1
- HQ: Cambridge
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.